http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63145224-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1986-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41240a10abde872cb5030f04e61e9166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1dbe632cd25619a7a049733b42b482c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a258dcba2e3a9f68fb8fd2673e3d1124 |
| publicationDate | 1988-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S63145224-A |
| titleOfInvention | Lysosome release inhibiting agent and histamine isolation inhibiting agent |
| abstract | PURPOSE: To obtain the titled pharmaceutical containing a cembrane type diterpene compound as an active ingredient, having strong affinity to inflammatory cell, inhibiting aggravation of inflammation, acting to chronic rheumatism or the like as well as mast cell and effective to colitis ulcerosa or the like. n CONSTITUTION: A cembrane type diterpene compound expressed by formula I or formula II (R is H or acyl group) is contained. The above-mentioned compound expressed by formula I or formula II is obtained from a coelenterate, Sarcophyton glaucum belonging to Gorgonacea. Namely the compound is separated from a lipid fraction of extract of the Sarcophyton glaucum by a silica gel chromatography. When extracted, the coelenterate is preferably dehydrated and finely cut so that the consistency of the surface is lost. And during the extraction treatment the coelenterate is preferably treated so as to minimize the contact area with air or under an inert gas atmosphere. n COPYRIGHT: (C)1988,JPO&Japio |
| priorityDate | 1986-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.